GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human DOT1L in complex with inhibitor FED2

Analyse Crystal structure of human DOT1L in complex with inhibitor FED2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4EQZ
Type
protein
Length
332 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase, H3 lysine-79 specific
EC
2.1.1.43
UniProt
Q8TEK3
Ligands
AW0, UNX
Pockets
2 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43)protein33245% helix, 14% strandQ8TEK3

Ligands and binding sites

  • AW0 · 5'-deoxy-5'-[(3-{[(4-methylphenyl)carbamoyl]amino}propyl)(propan-2-yl)amino]adenosine · ligand · chains A
  • UNX · Unknown atom or ion · ion · 6 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14940.730.8159AW0, UNX
2680.300.7310empty

Compared structures

  • 4EQZ · Crystal structure of human DOT1L in complex with inhibitor FED2 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8TEK3 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase, H3 lysine-79… · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.